Publication | Closed Access
Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers
65
Citations
0
References
2017
Year
OncologyKeynote-158 StudiesMedicineImmunologyPathologyImmune Checkpoint InhibitorCancer GeneticsPhase 2Cancer BiologyRadiation OncologyCancer Research
No additional data available for this publication yet. Check back later!